Patent ID: 11858937
Assignee: QURIENT CO., LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 1:
2. The compound according to claim 1, wherein the compound has Formula Ia:, or a pharmaceutically acceptable salt or stereoisomer thereof,
wherein:
Q is —C(O)—, —C(O)CH2—, —NH—, —NHCH2—, —NHC(O)—, —NHS(O)2—, —O—, or —OCH2—;
Y1 is CH, COH, or N;
Y2 is CH, COH, or N;
R3 is H, halogen, C1-C6 alkyl, C(O)NH2, NR5R5, NHC(O)R5, or OH, wherein the C1-C6 alkyl is optionally substituted with one substituent selected from the group consisting of NH2 and OH;
each R4 is independently H, halogen, C1-C6 alkyl, NH2, or OR5, wherein each C1-C6 alkyl is optionally and independently substituted with one substituent selected from the group consisting of NH2 and OH;
each R5 is independently H, C1-C6 alkyl, or C1-C3 haloalkyl;
W is a structure selected from the following Group C:, and
R22 is H, halogen, CN, C1-C6 alkyl, NR5R5, NR19R20, OR5, C3-C10 cycloalkyl, or heterocyclyl.